Company intelligence / Profile preview
Sacred Medicines
- Ownership
- Private
- Development stage
- Other
Overview
Sacred Medicines is a Public Benefit Corporation (PBC) focused on developing standardized whole plant medicines to treat mental health conditions. Founded in 2020 by Dr. Leanna Standish and Dr. Victoria Hale, the company is initially focused on establishing an FDA regulatory pathway for a standardized Ayahuasca tea. Sacred Medicines cultivates its botanical ingredients, Banisteriopsis caapi and Psychotria viridis, organically at an ethnobotanical preserve in Hawaii to ensure sustainable sourcing and avoid chemical waste. The company aims to demonstrate the safety and efficacy of its botanical drug product through group therapy clinical trials while prioritizing reciprocity and ecological stewardship with Indigenous communities.
- Therapeutic areas
- Psychiatry
- Modalities
- Botanical extractSmall molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Sacred Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sacred Medicines.